ROMAZICON Drug Patent Profile
✉ Email this page to a colleague
When do Romazicon patents expire, and what generic alternatives are available?
Romazicon is a drug marketed by Hoffmann La Roche and is included in one NDA.
The generic ingredient in ROMAZICON is flumazenil. There are four drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the flumazenil profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Romazicon
A generic version of ROMAZICON was approved as flumazenil by BAXTER HLTHCARE CORP on October 12th, 2004.
Summary for ROMAZICON
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 136 |
Clinical Trials: | 4 |
Patent Applications: | 3,157 |
Formulation / Manufacturing: | see details |
DailyMed Link: | ROMAZICON at DailyMed |
Recent Clinical Trials for ROMAZICON
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Prisma Health-Midlands | Early Phase 1 |
Sameh Hanna, MD | Early Phase 1 |
University of California, Davis | Phase 4 |
Anatomical Therapeutic Chemical (ATC) Classes for ROMAZICON
US Patents and Regulatory Information for ROMAZICON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Hoffmann La Roche | ROMAZICON | flumazenil | INJECTABLE;INJECTION | 020073-001 | Dec 20, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Hoffmann La Roche | ROMAZICON | flumazenil | INJECTABLE;INJECTION | 020073-002 | Dec 20, 1991 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for ROMAZICON
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Hoffmann La Roche | ROMAZICON | flumazenil | INJECTABLE;INJECTION | 020073-001 | Dec 20, 1991 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for ROMAZICON
See the table below for patents covering ROMAZICON around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Ireland | 50318 | IMIDAZODIAZEPINE DERIVATIVES | ⤷ Try a Trial |
Spain | 8304132 | ⤷ Try a Trial | |
Japan | S5659776 | IMIDAZODIAZEPINE DERIVATIVE | ⤷ Try a Trial |
Spain | 505213 | ⤷ Try a Trial | |
>Country | >Patent Number | >Title | >Estimated Expiration |